The content on this site is intended for healthcare professionals only
Dr Veronesi discusses her article published in the Biomarkers, Screening and Prevention in Cancer special issue.
She explains the benefits of low dose CT screening, which individuals should undergo screening and whether the original screening trials turned out to be positive.
Read Dr Veronesi’s article here.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Revolutionising myeloma treatment through immune profiling
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Looking at real world evidence on PSA testing in prostate cancer
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA
Lung cancer screening and treatment in the Philippines
Evidence-based approach to lymph node assessment and targeted axillary dissection
